Albumin-to-fibrinogen ratio as a promising biomarker to predict clinical outcome of non-small cell lung cancer individuals.

导出 LinkOut

翻译打印收藏纠错

第一作者： Shu-Qi,Li

第一单位： Department of Clinical Laboratory, Jiangxi Province Key Laboratory of Laboratory Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi, China.

作者： Shu-Qi,Li ^[1] ; Yu-Huan,Jiang ^[1] ; Jin,Lin ^[1] ; Jing,Zhang ^[1] ; Fan,Sun ^[1] ; Qiu-Fang,Gao ^[1] ; Lei,Zhang ^[1] ; Qing-Gen,Chen ^[1] ; Xiao-Zhong,Wang ^[1] ; Hou-Qun,Ying ^[1]

作者单位： Department of Clinical Laboratory, Jiangxi Province Key Laboratory of Laboratory Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi, China. ^[1]

关键词 Albumin-to-fibrinogen ratio nomogram non-small cell lung cancer prognosis

主题词老年人(Aged);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);女(雌)性(Female);纤维蛋白原(Fibrinogen);人类(Humans);Kaplan-Meiers评估(Kaplan-Meier Estimate);肺肿瘤(Lung Neoplasms);男(雄)性(Male);中年人(Middle Aged);预后(Prognosis);危险因素(Risk Factors)

DOI 10.1002/cam4.1428

PMID 29533009

发布时间 2024-03-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览63

Cancer medicine

2018年7卷4期

1221-1231页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Albumin-to-fibrinogen ratio as a promising biomarker to predict clinical outcome of non-small cell lung cancer individuals.

Cancer medicine

相似文献

Cancer medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Albumin-to-fibrinogen ratio as a promising biomarker to predict clinical outcome of non-small cell lung cancer individuals.

Cancer medicine

相似文献

Cancer medicine

相关期刊

检索历史清除